Navigation Links
EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting

isorder (MDD). The trial is designed to evaluate the effect of treatment with up to 120 mg of PRX-00023 twice-daily for eight weeks as determined by change from baseline in MADRS compared with placebo. Data from this trial are expected in the first half of 2008.

About PRX-00023

PRX-00023 is a novel, highly selective, once-daily, 5-HT1A partial agonist discovered using the company's proprietary G-Protein Coupled Receptors (GPCR) modeling, screening and lead optimization technology. PRX-00023 is targeting a significant unmet medical need and commercial opportunity for a selective, once-daily, 5-HT1A agonist used in the treatment of depression that avoids the sexual dysfunction, withdrawal symptoms and sleep disturbances typically associated with selective serotonin reuptake inhibitors (SSRIs) and serotonin noradrenaline reuptake inhibitors (SNRIs), lacks the addictive and sedative effects of the benzodiazepines, and does not have the slow onset, short half-life, and side effects of a chemical class of 5-HT1A agonists called azapirones. PRX-00023 is the subject of a composition of matter patent held by EPIX which extends through 2024.

About EPIX

EPIX Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products through the use of proprietary technology to better diagnose, treat and manage patients. The company has five internally-discovered therapeutic and imaging drug candidates currently in clinical trials targeting conditions such as depression, Alzheimer's disease, cardiovascular disease and obesity. These drug candidates include PRX-08066 in Phase 2 clinical development for pulmonary hypertension associated with chronic obstructive pulmonary disease, PRX-03140 which is in a Phase 2a clinical trial in Alzheimer's disease, PRX-00023 which is in Phase 2b clinical development to treat major depression, and PRX-07034, which recently completed a Phase 1b trial and is in cli
'"/>




Page: 1 2 3 4

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
4. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
11. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
Post Your Comments:
(Date:9/19/2014)... Larry J. Merlo , President and CEO of CVS ... National Press Club in Washington, D.C. ... selling tobacco products and its leadership in driving the innovations ... changes in our health care system pose enormous challenges to ... "CVS Health has a truly unique combination of business assets ...
(Date:9/19/2014)... WALTHAM, Mass. , Sept. 19, 2014  Alere ... in rapid diagnostics, issued the following statement today in ... Combating Antibiotic-Resistant Bacteria. "As the global leader ... President for establishing a national strategy to address the ... continuing to work with the Administration on initiatives to ...
(Date:9/19/2014)... DIEGO , Sept. 19, 2014  Lpath, ... leader in bioactive lipid-targeted therapeutics, announced today that ... 3,605,042 registered shares of common stock and 3,605,042 ... combined purchase price for one registered share of ... one unregistered share of common stock will be ...
Breaking Medicine Technology:CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 3Alere Applauds President's Executive Order Combating Antibiotic-Resistant Bacteria 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3
... Mich., April 28, 2011 Perrigo Company (Nasdaq: ... declared a quarterly dividend of $0.07 per share, ... record on May 27, 2011. Perrigo ... develops, manufactures and distributes over-the-counter (OTC) and generic ...
... 2011 Q1 2011 Change on a reported basis ... A/H1N1 salesNet sales , euro 7,779m-1.5% , -5.2% ... -16.1% , -5.8%Business EPS(1)euro 1.66-10.8%-16.1%-6.0% In order to facilitate ... our business net income statement. Business net income(1) is ...
Cached Medicine Technology:sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 2sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 3sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 4sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 5sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 6sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 7sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 8sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 9sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 10sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 11sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 12sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 13sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 14sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 15sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 16sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 17sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 18sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 19sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 20sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 21sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 22sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 23sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 24sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 25sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 26sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 27sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 28sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 29sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 30sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 31sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 32
(Date:9/21/2014)... OH (PRWEB) September 21, 2014 C8 ... District of Ohio as the list of 20 possible ... been narrowed down to six, reports Wright & Schulte ... chosen from the almost 2500 C8 lawsuits filed that ... or testicular cancer as a result of being exposed ...
(Date:9/20/2014)... Recently, iFitDress.com, a well-known wedding dress manufacturer and retailer, ... . In addition, the company has launched a special offer ... is to benefit all of its big fans. Worldwide people ... , Along with beautiful party dresses, the company also ... released its new sexy short prom outfits and purple homecoming ...
(Date:9/20/2014)... Weight Destroyer , a weight loss ... Wren that has already helped tens of thousands of ... like high blood pressure, high cholesterol, and accelerated aging ... investigative review. , “Weight Destroyer is totally turning ... showing people what is truly effective when it comes ...
(Date:9/20/2014)... September 20, 2014 The Villa Group ... del Palmar Cabo San Lucas, Villa La Estancia and ... Hurricane Odile, with plans to welcome guests back to ... of Sept. 19, all members and guests of the ... to a coordinated effort with government authorities. , ...
(Date:9/20/2014)... NY (PRWEB) September 20, 2014 Ticket ... Grande concert tickets . This popular ticket exchange is ... , The 2015 schedule of tours is beginning ... have already announced their plans to hit the road, including ... Raton, Fla., announced the “Honeymoon Tour,” which will take her ...
Breaking Medicine News(10 mins):Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 2Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 3Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 4Health News:Beautiful Party Dresses For Autumn Unveiled By iFitDress.com 2Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 2Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 3Health News:Villa Group Resorts in Cabo Largely Unharmed, Plan to Re-open Early October 2Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 2Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 3
... , ... and his foundation to raise money to help the people of Haiti. It is Mr. Kent and ... ... Capital, LLC., and CEO of the Kent Marketing Group to join forces with former NFL player Jack ...
... ... April 1 – May 30, people age 65 and older can call to determine if they ... ... of change, but don’t worry if you don’t have the change to spare for an eye ...
... The American Academy ... wrinkles that become etched into the surface of the skin and don,t disappear once you,re ... the face and the pillow, allowing the delicate facial skin, to remain smooth for the ... ...
... ... MDX/American Registry Medical Patient,s Choice Award. , ... (Vocus) March 30, 2010 -- Five Summit Medical Group physicians ... Gruber, M.D., Jed A. Kwartler, M.D., Eric Mrisky, M.D., and Monib Zirvi, M.D., join ...
... ... Processes, an internationally recognized leader in literacy research, remediation, and professional development, will ... campaign beginning April 1st, 2010. , ... San Luis Obispo, CA (Vocus) -- Lindamood-Bell ...
... Global Initiative (BHGI) and the Latin American & Caribbean ... biennial BHGI Global Summit on International Breast Health June ... international organizations to address the optimization of breast health ... 2010 Summit is "Optimizing Health Care Delivery." ...
Cached Medicine News:Health News:Thomas J. Kent Jr. FDP Capital, LLC Chairman and Former NFL Player Jack Brewer Join Forces 2Health News:EyeCare America Ushers in the New Season and Springs for Eye Exams for Qualified Seniors 2Health News:EyeCare America Ushers in the New Season and Springs for Eye Exams for Qualified Seniors 3Health News:Mumbani™ Fresh Face Pillow, an Anti-Aging and Anti-Wrinkle Sleep Accessory for Side and Stomach Sleepers! 2Health News:Mumbani™ Fresh Face Pillow, an Anti-Aging and Anti-Wrinkle Sleep Accessory for Side and Stomach Sleepers! 3Health News:Summit Medical Group Physicians Receive Patients' Choice Award 2Health News:Summit Medical Group Physicians Receive Patients' Choice Award 3Health News:Lindamood-Bell to Help Commemorate Autism Awareness Day 2Health News:Lindamood-Bell to Help Commemorate Autism Awareness Day 3Health News:Lindamood-Bell to Help Commemorate Autism Awareness Day 4Health News:The Global Summit on International Breast Health 2
... The AngioJet Xpeedior+120 Rheolytic Thrombectomy catheter is ... performance. Powerful saline jets create a low ... a vacuum effect. Thrombus is drawn into ... the jets, and removed from the body.,AngioJet ...
... CARTO XP Electroanatomical Mapping System combines the ... the operating ease of Windows* software. ... adding powerful new tools that enhance your ... takes you into the future of EP. ...
... generators are meeting the clinical needs ... and anesthesiologists. And, they are of ... from Medtronic.,Effective pacing with the adjustment ... for quick battery changes. Both ...
... Medtronic's temporary pulse generators are ... surgeons, nurses, cardiologists, electrophysiologists and anesthesiologists. ... and durability you expect from Medtronic.,Effective ... Reverse battery polarity for quick ...
Medicine Products: